Boston Scientific agrees distribution and investment deal with Preventice Solutions

Boston Scientific has agreed to become the exclusive worldwide sales and marketing representative for Preventice Solutions' range of cardiology-related diagnostic and monitoring offerings.

Preventice Solutions is a leading developer of mobile health solutions and services, offering a full portfolio of wearable cardiac monitors, such as Holter monitors, cardiac event monitors and mobile cardiac telemetry.

This deal will expand Boston Scientific's commercial presence in the cardiac diagnostics and monitoring market, providing it with access to an innovative wireless monitoring portfolio linked to an integrated remote monitoring platform.

As part of the agreement, Boston Scientific has also made an equity investment in Preventice Solutions and is now a significant shareholder in the company.

Joe Fitzgerald, executive vice-president and president of rhythm management at Boston Scientific, said: "This collaboration with Preventice Solutions, which has an infrastructure optimised to monitor hundreds of thousands of patients each year, is a critical step in our effort to improve patient outcomes and reduce healthcare costs."

This comes in the same week that the firm closed its acquisition of American Medical Systems' male urology portfolio.